Canadian Immunization Guide: Part 1 - Key Immunization Information

Recommended Immunization Schedules

Updated: July 2016

General Recommendations

Administration of vaccines in accordance with the immunization schedules summarized in the following tables will provide optimal protection from vaccine preventable diseases for most individuals. However, modifications of the recommended schedule may be necessary due to missed appointments or illness. In general, interruption of an immunization series does not require restarting the vaccine series, regardless of the interval between doses. Individuals with interrupted immunization schedules should be vaccinated to complete the appropriate schedule for their current age. Refer to Timing of Vaccine Administration in Part 1 and vaccine-specific chapters in Part 4 for additional information.

Similar, but not identical, vaccines may be available from different manufacturers; therefore, it is useful to review the relevant vaccine-specific chapters in the Canadian Immunization Guide as well as the manufacturer's product leaflet or product monograph before administering a vaccine. Refer to Principles of Vaccine Interchangeability in Part 1 for information about the interchangeability of similar vaccines from different manufacturers. Product monographs are periodically updated; it is a best practice to consult the information contained within the product monographs available through Health Canada's Drug Product Database.

Table 1: Routine Childhood Immunization Schedule, Infants and Children (birth to 17 years of age)

Table 1: Routine Childhood Immunization Schedule, Infants and Children (birth to 17 years of age)
VaccineFootnote * Age
Birth 2 mos 4 mos 6 mos 12 mos 15 mos 18 mos 23 mos 2 years 4 years 5 years 6 years 9 years 12 years 14 years 15 years 16 years 17 years
DTaP-IPV-Hib
or
DTaP-HB-IPV-Hib
  Table 1 - Footnote A
or Table 1 - Footnote B
1st dose
Table 1 - Footnote A
or Table 1 - Footnote B
2nd dose
Table 1 - Footnote A
or Table 1 - Footnote B
3rd dose
Table 1 - Footnote A
or 4th dose
Generally at 18 months of age
                   
DTaP-IPV
or
Tdap-IPV
                  Table 1 - Footnote C            
Tdap                             Table 1 - Footnote D  
Rot   Table 1 - Footnote E
2 or 3 doses
Complete series before 8 months
                           
Pneu-C-13   Table 1 - Footnote F Table 1 - Footnote F                        
Men-C-C   Table 1 - Footnote [G]
According to P/T schedule
Table 1 - Footnote G
Generally at 12 months
               
Men-C-C
or
Men-C-ACYW
                          Table 1 - Footnote H        
MMR and Var         Table 1 - Footnote I + Table 1 - Footnote J Table 1 - Footnote I + Table 1 - Footnote J            
OR
MMRV         Table 1 - Footnote K Table 1 - Footnote K
Generally at 4-6 years
           
HB Table 1 - Footnote L
3 doses
                         
OR
HB                         Table 1 - Footnote M
2 or 3 doses
HPV                         Table 1 - Footnote N
2 or 3 doses
     
OR
HPV                               Table 1 - Footnote O
3 doses
Inf       Table 1 - Footnote P
1 or 2 doses
Recommended annually
Table 1 - Footnote P
1 dose
Recommended annually

Table 2: Recommended Immunization Schedule, Children (less than 7 years of age), NOT Previously Immunized as Infants

Table 2: Recommended Immunization Schedule, Children (less than 7 years of age), NOT Previously Immunized as Infants
VaccineFootnote * 1st visit Time after 1st visit 6-12 mos
after last dose
4 weeks 8 weeks 3 mos 4 mos 6 mos
DTaP-IPV-Hib
or
DTaP-IPV
Footnote A   Footnote A   Footnote A   Footnote A Footnote [B]
Pneu-C-13 Footnote [C]   Footnote [C]        
Men-C-C Footnote D            
MMR Footnote E Footnote E          
Var Footnote F     Footnote F      
OR
MMRV Footnote G     Footnote G      
HB Footnote [H] Footnote [H]       Footnote [H]  
Inf Footnote I Footnote I          

Table 3: Recommended Immunization Schedule, Children (7 to 17 years of age), NOT Previously Immunized

Table 3: Recommended Immunization Schedule, Children (7 to 17 years of age), NOT Previously Immunized
VaccineFootnote * 1st visit Time after first visit 6-12 mos after last dose 10 yrs after last dose
4 weeks 8 weeks 3 mos 6 mos
Tdap-IPV
Tdap
Footnote A     Footnote A   Footnote A Footnote B
Men-C-C Footnote [C]
7-11 years of age
           
OR
Men-C-C
or
Men-C-ACYW
Footnote D
12-17 years of age
           
MMR Footnote E Footnote E          
Var Footnote F       Footnote F    
OR
MMRV Footnote G
7-12 years of age
    Footnote G      
HB Footnote H Footnote [H]     Footnote H    
HPV Footnote I
9-14 years of age
      Footnote I    
OR
HPV Footnote I
9-14 years of age
3 doses
   
OR
HPV Footnote J
15-17 years of age
3 doses
   
Inf Footnote K
7-8 years of age
Footnote K          
OR
Inf Footnote K
9-17 years of age
           

Table 4: Additional Recommended Immunizations, Children (birth to 17 years of age), Considered AT RISK due to Underlying Medical Conditions

Table 4: Additional Recommended Immunizations, Children (birth to 17 years of age), Considered AT RISK due to Underlying Medical Condition
VaccineFootnote * Age
Birth 2 mos 6 mos 12 mos 15 mos 18 mos 23 mos 2 years 3 years 5-8 yrs 9-17 yrs
Hib                   Footnote A
1 dose
Pneu-P-23               Footnote B
1 dose + 1 booster dose if at highest risk
Pneu-C-13     Footnote C           Footnote [C]
If not previously received
Men-C-ACYW   Footnote D
2, 3 or 4 doses + additional booster doses
 
4CMenB   Footnote E
2, 3 or 4 doses + additional booster doses
HA       Footnote F
2 doses
HB Footnote G
3 or 4 doses
Inf     Footnote H
1 or 2 doses
Recommended annually
Footnote H
1 dose
Recommended annually

Table 5: Recommended Immunization Schedule, Adults (18 years of age and older), NOT Previously Immunized

Table 5: Recommended Immunization Schedule, Adults (18 years of age and older), NOT Previously Immunized
VaccineFootnote * 1st visit Time after 1st visit 6-12 mos after last dose 10 years after last dose
4 weeks 6 weeks 8 weeks 6 mos
Tdap-IPV
Td-IPV
Td
Footnote A     Footnote B   Footnote B Footnote C
MMR Footnote [D]            
Var Footnote [E]
18-49 years of age
  Footnote [E]        
OR
HZV Footnote [F]
50 years of age and over
           
Pneu-P-23 Footnote [G]            
Men-C-C
or
Men-C-ACYW
Footnote [H]
18-24 years of age
           
HPV Footnote I
3 doses
   
Inf Footnote J
Annually

Table 6: Recommended Immunizations, Adults (18 years of age and older), Previously Immunized

Table 6: Recommended Immunizations, Adults (18 years of age and older), Previously Immunized
VaccineFootnote * Age
18-26 years 27-49 years 50-59 years 60 years 65 years and older
Td Footnote A
1 dose every 10 years
Tdap Footnote B
1 dose
Pneu-P-23         Footnote C
1 dose
HZV       Footnote D
1 dose
Inf Footnote E
Anually

Table 7: Additional Recommended Immunizations, Adults (18 years of age and older), Considered AT RISK

Table 7: Additional Recommended Immunizations, Adults (18 years of age and older), Considered AT RISK
VaccineFootnote * Age
18 years of age and older
Hib Footnote A
1 dose
IPV Footnote B
1 booster dose
MMR Footnote C
Second dose
Pneu-C-13 Footnote D
1 dose
Pneu-P-23 Footnote E
1 dose + 1 booster dose if at highest risk
Men-C-ACYW Footnote F
2 doses + booster doses
4CMenB Footnote G
2 doses
HA Footnote H
2 doses
HB Footnote I
3 or 4 doses
OR
HAHB Footnote J
3 or 4 doses
Inf Footnote K
Annually
Typh-I Footnote L
1 dose + booster doses if at ongoing risk
OR
Typh-O Footnote L
4 doses + booster doses if at ongoing risk
BCG Footnote M
1 dose
Rab Footnote N
3 doses + booster doses if required
Date modified: